Recent progress in drug delivery systems for anticancer agents.
Recent progress in understanding the molecular basis of cancer brought out new materials such as oligonucleotides, genes, peptides and proteins as a source of new anticancer agents. Due to their macromolecular properties, however, new strategies of delivery for them are required to achieve their full therapeutic efficacy in clinical setting. Development of improved dosage forms of currently marketed anticancer drugs can also enhance their therapeutic values. Currently developed delivery systems for anticancer agents include colloidal systems (liposomes, emulsions, nanoparticles and micelles), polymer implants and polymer conjugates. These delivery systems have been able to provide enhanced therapeutic activity and reduced toxicity of anticancer agents mainly by altering their pharmacokinetics and biodistribution. Furthermore, the identification of cell-specific receptor/antigens on cancer cells have brought the development of ligand- or antibody-bearing delivery systems which can be targeted to cancer cells by specific binding to receptors or antigens. They have exhibited specific and selective delivery of anticancer agents to cancer. As a consequence of extensive research, clinical development of anticancer agents utilizing various delivery systems is undergoing worldwide. New technologies and multidisciplinary expertise to develop advanced drug delivery systems, applicable to a wide range of anticancer agents, may eventually lead to an effective cancer therapy in the future.
Kim
Chong-Kook
CK
National Research Lab for Drug and Gene Delivery, College of Pharmacy, Seoul National University, Kwanak-Gu, Korea. ckkim@plaza.snu.ac.kr
Lim
Soo-Jeong
SJ
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000627:therapeutic use; D003102:Colloids; D016503:Drug Delivery Systems; D004343:Drug Implants; D006801:Humans; D008081:Liposomes; D008863:Microspheres
D000970:Antineoplastic Agents; D003102:Colloids; D004343:Drug Implants; D008081:Liposomes